Company press releases
| Tid | Selskap | Tittel | Sektor | Kategori |
|---|---|---|---|---|
| 08 Dec 2025 13:30 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 08 Dec 2025 13:30 CET |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 31 Oct 2025 07:40 CET |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter and YTD 2025 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 24 Oct 2025 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2025 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 15 Aug 2025 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and YTD 2025 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 08 Aug 2025 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2025 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jun 2025 08:00 CEST |
VISTIN PHARMA | Ex dividend NOK 1.25 today | 20103015 Pharmaceuticals | Ex Date |
| 23 May 2025 11:22 CEST |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2025 11:22 CEST |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 22 May 2025 14:59 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2025 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 May 2025 11:56 CEST |
VISTIN PHARMA | Disclosure of voting rights at AGM in Vistin Pharma ASA | 20103015 Pharmaceuticals | Total number of voting rights and capital |
| 07 May 2025 15:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA (VISTN): Update from the Election Committee | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 06 May 2025 15:03 CEST |
VISTIN PHARMA | Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 29 Apr 2025 11:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Apr 2025 16:40 CEST |
VISTIN PHARMA | 2024 Annual Report Vistin Pharma ASA | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 25 Apr 2025 07:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2025 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 15 Apr 2025 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2025 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Feb 2025 12:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Key information relating to the proposed cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Feb 2025 07:35 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 06 Feb 2025 11:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 09:13 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Dec 2024 09:13 CET |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 06 Nov 2024 07:45 CET |
VISTIN PHARMA | Ex dividend NOK 0.50 today | 20103015 Pharmaceuticals | Ex Date |
| 31 Oct 2024 07:40 CET |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter and YTD 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 24 Oct 2024 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 21 Oct 2024 17:00 CEST |
VISTIN PHARMA | Responsibility statement for first half year of 2024 | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 26 Sep 2024 17:27 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 13 Sep 2024 17:10 CEST |
VISTIN PHARMA | Disclosure of large shareholding and mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2024 16:06 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2024 07:40 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2024 10:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 05 Jun 2024 08:05 CEST |
VISTIN PHARMA | Ex dividend NOK 0.50 today | 20103015 Pharmaceuticals | Ex Date |
| 23 May 2024 14:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the annual general meeting 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 May 2024 12:56 CEST |
VISTIN PHARMA | Disclosure of voting rights at AGM in Vistin Pharma ASA | 20103015 Pharmaceuticals | Total number of voting rights and capital |
| 30 Apr 2024 08:58 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Notice of Annual General Meeting 23 May 2024 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 24 Apr 2024 23:10 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report 2023 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 24 Apr 2024 07:44 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2024 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Apr 2024 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2024 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Mar 2024 21:59 CET |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Mar 2024 08:15 CET |
VISTIN PHARMA | Vistin Pharma ASA (VISTN) acquires minority share in CF Pharma (Hungary) | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 10:30 CET |
VISTIN PHARMA | Vistin Pharma ASA: Key information relating to the proposed cash dividend | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 16 Feb 2024 07:45 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 09 Feb 2024 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 23 Jan 2024 08:00 CET |
VISTIN PHARMA | Ex dividend NOK 0.75 today | 20103015 Pharmaceuticals | Ex Date |
| 11 Jan 2024 11:40 CET |
VISTIN PHARMA | Key information relating to the cash dividend to be paid by Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 Jan 2024 11:35 CET |
VISTIN PHARMA | Vistin Pharma ASA: Dividend of NOK 0.75 per share | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 13 Dec 2023 10:21 CET |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Third quarter 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 25 Oct 2023 07:45 CEST |
VISTIN PHARMA | Vistin Pharma ASA: New CEO appointed | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 18 Oct 2023 13:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q3 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |